Development

INSIGHTS ON DRUG DEVELOPMENT

3D Cell Culture Reveals Undetectable Drug Efficacy In Traditional Systems
Drug discovery now targets cancer stem cells (CSCs) to achieve long-term tumor eradication, which moves beyond traditional chemotherapeutics. Discover an advanced screening platform that better predicts CSC inhibitor efficacy.
Expanding Translational Research Concepts With Genedata Profiler
The biopharma industry leverages Genedata Profiler to integrate, curate, and analyze diverse R&D data, enabling collaborative, compliant, and AI-driven translational research to optimize drug development.
Understand Fluorescence And How It Enhances Scientific Exploration
Deepen your understanding of fluorescence for research, and gain valuable insight into how to select appropriate fluorophores and fluorescent proteins for your experiments.
UPLC-MS/MS Determination Of GLP-1 Analogue
Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.

3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived Neurons
4/4/2025

Explore how different ApoE alleles influence Alzheimer's Disease risk using iPSC-derived neurons as well as gain insights into AD mechanisms and potential therapies.
Leveraging Softgel To Extend Vinorelbine's Lifecycle, Improve Patient Convenience
3/20/2026

Develop innovative oral formulations of traditionally intravenous therapies to enhance patient convenience, ensure consistent systemic exposure, and support long-term brand value and market differentiation.
From 51% Yield To 87% With Targeted Impurity Removal
5/7/2026

Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.
Why Biopharma Breakthroughs Aren't Moving The Market
10/20/2025

Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.
Silencing CDMO Project Noise: The Power Of Low-Drama Drug Development
3/3/2026

Move beyond reactive firefighting by prioritizing disciplined leadership and data-driven milestones. The winning model for complex programs is focused, high-maturity, low-drama execution.

Trusted End-To-End CDMO Partner For Your Journey

Partner with a trusted, globally proven CDMO whose world-class, rapidly scalable facilities and unwavering commitment to quality help accelerate patient access to life-saving biologics.
Which Organ-Chip Design Is Right For You?

Explore detailed product specifications and utilize a helpful decision tree to determine which organ-chip best meets the needs of your research.
Multi-Mode Microplate Reader For Assay Flexibility

Precise optics, fluidic transfer, and assay flexibility on one integrated microplate reader.
One-Touch DNA, RNA, And Protein Quantitation In A Spectrophotometer

Standalone instrument with touchscreen and built-in sample ports for small volumes and cuvettes

The SpectraMax® QuickDrop™ Micro-Volume Spectrophotometer quantifies very small amounts of DNA, RNA, oligos, and proteins.
Transforming Tissue Research With Open Multiplexing

Cell DIVE Multiplex Imaging Solution

What if every scientist could map normal and diseased tissue by cell type, biomarker profile, and specific features?

Cell DIVE is a precise, open multiplexing solution that lets your research dictate the level of automation required, which antibodies to use, how to build your antibody panel, and more.